These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3096766)

  • 1. The assessment of almitrine bismesylate in the long-term treatment of chronic obstructive bronchitis.
    Marsac J
    Eur J Respir Dis Suppl; 1986; 146():685-93. PubMed ID: 3096766
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of almitrine bismesylate 100 mg daily for four weeks on respiratory regulation in patients with chronic bronchitis.
    Stanley NN
    Eur J Respir Dis Suppl; 1986; 146():635-9. PubMed ID: 3096763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term studies on almitrine bismesylate in COPD patients.
    Bourgouin-Karaouni D; Mercier J; Prefaut C
    Eur J Respir Dis Suppl; 1986; 146():695-701. PubMed ID: 3096767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of almitrine dimesylate in the long-term treatment of chronic obstructive bronchitis].
    Seignalet C; Miech G
    Rev Med Interne; 1985; 6 Spec No():21-9. PubMed ID: 3938854
    [No Abstract]   [Full Text] [Related]  

  • 5. Long term almitrine bismesylate treatment in patients with chronic bronchitis and emphysema: a multicentre double-blind placebo controlled study.
    Arnaud F; Bertrand A; Charpin J; Chretien J; Decroix G; Guerrin F; Kalb JC; Lissac J; Michel FB; Morere P
    Eur J Respir Dis Suppl; 1983; 126():323-36. PubMed ID: 6373343
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of almitrine bismesylate on arterial blood gases and ventilatory drive in patients with severe chronic airflow obstruction and bilateral carotid body resection.
    de Backer W; Bogaert E; Van Maele R; Vermeire P
    Eur J Respir Dis Suppl; 1983; 126():239-42. PubMed ID: 6426993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung function after almitrine bismesylate administration in a five year old boy with chronic airways obstruction.
    Gaultier C; Boule M; Mercier JC; Beaufils F
    Eur J Respir Dis Suppl; 1983; 126():319-21. PubMed ID: 6426995
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of almitrine bismesylate on nocturnal hypoxemia in patients with chronic bronchitis and obesity.
    Marrone O; Milone F; Coppola P; Oddo S; Giannone G; Macaluso C; Bonsignore G
    Eur J Respir Dis Suppl; 1986; 146():641-8. PubMed ID: 3096764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Almitrine bismesylate in chronic obstructive lung disease and persistent hypoxemia. Controlled double-blind study with oral administration].
    Wuttke R; von Wichert P
    Respiration; 1985; 48(4):285-95. PubMed ID: 3936140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of almitrine bismesylate on chemosensitivity in patients with chronic airways obstruction.
    Stanley NN; Pieczora JA; Pauly N
    Eur J Respir Dis Suppl; 1983; 126():233-7. PubMed ID: 6426992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Almitrine in daily practice].
    Bourgouin-Karaouni D; Préfaut C
    Rev Med Interne; 1985; 6 Spec No():15-20. PubMed ID: 3938853
    [No Abstract]   [Full Text] [Related]  

  • 12. Pattern of breathing and gas exchange following oral almitrine bismesylate in patients with chronic obstructive pulmonary disease.
    Stradling JR; Nicholl CG; Cover D; Davies EE; Hughes JM; Pride NB
    Eur J Respir Dis Suppl; 1983; 126():255-64. PubMed ID: 6373340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of almitrine bismesylate in acute respiratory failure.
    Lambropoulos S; Chatzipappas A; Tsekos G; Tsantoulis K
    Eur J Respir Dis Suppl; 1986; 146():657-61. PubMed ID: 3465586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary hemodynamic effects of intravenous almitrine in patients with chronic bronchitis and respiratory insufficiency].
    Weitzenblum E; Ehrhart M; Schneider JC; Hirth C; Roegel E
    Bull Eur Physiopathol Respir; 1982; 18(5):765-73. PubMed ID: 6152773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of hematosis disorders in chronic obstructive bronchitis with almitrine bismesilate].
    Raimondi GA
    Medicina (B Aires); 1987; 47(6):687-8. PubMed ID: 3504999
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of chronic obstructive bronchitis with almitrine].
    Pilheu JA
    Medicina (B Aires); 1987; 47(4):442. PubMed ID: 2898724
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of hematosis disorders in chronic obstructive bronchitis with almitrine bismesylate].
    González Montaner LJ
    Medicina (B Aires); 1986; 46(6):739-41. PubMed ID: 3306258
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of almitrine at rest and on exercise in COPD patients.
    Feist H
    Eur J Respir Dis Suppl; 1986; 146():651-5. PubMed ID: 3096765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Almitrine bismesylate].
    Duroux P
    Rev Mal Respir; 1985; 2 Suppl 1():S1-2. PubMed ID: 2870541
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic importance and tolerance of coated 50 mg Vectarion tablets (almitrine bismesylate) at a dosage of 100 mg/day. Study of blood gas, clinical and biological results after a year of long-term treatment].
    Ansquer JC; Bertrand A; Blaive B; Charpin J; Chrétien J; Decroix G; Kalb JC; Lissac J; Michel FB; Morère P
    Rev Mal Respir; 1985; 2 Suppl 1():S61-7. PubMed ID: 2870549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.